Nonclinical services for the development of interventional agents for infectious diseases.
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Eurofins Discovery Services North America, LLC UEI HF4LCAU68M93
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $282,748
Award facts
- Contract value 68% obligated
-
- $282,748.00 Current, with exercised options
- $415,004.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Weldon Spring, MO 63304, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$49,716 | |
| Exercise an Option | $3,028 | |
| Exercise an Option | $35,206 | |
| Exercise an Option | $35,206 | |
| Original award | $259,024 |
About this award
The National Institute of Allergy and Infectious Diseases issued a $415,004 delivery order to Eurofins Discovery Services North America, LLC on December 16, 2020, under the Nonclinical Services for Development of Interventional Agents parent IDIQ for nonclinical services supporting the development of interventional agents for infectious diseases.
Place of performance is Weldon Spring, Missouri. The order carries an ultimate completion date of April 30, 2025, and is priced on a firm fixed-price basis. The delivery order was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of those funds. No set-aside was used.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 16, 2020.
How much is contract 75N93021F00001 worth?
The government has obligated $282,748 on 75N93021F00001. Its potential value, with all options, is $415,004.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93018D00007, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award